• Part 200 [§ 200.5 - § 200.200] - PART 200—GENERAL

• Part 201 [§ 201.1 - § 201.328] - PART 201—LABELING

• Part 202 [§ 202.1 - § 202.1] - PART 202—PRESCRIPTION DRUG ADVERTISING

• Part 203 [§ 203.1 - § 203.70] - PART 203—PRESCRIPTION DRUG MARKETING

• Part 205 [§ 205.1 - § 205.50] - PART 205—GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS

• Part 206 [§ 206.1 - § 206.10] - PART 206—IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE

• Part 207 [§ 207.1 - § 207.81] - PART 207—REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE

• Part 208 [§ 208.1 - § 208.26] - PART 208—MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS

• Part 209 [§ 209.1 - § 209.11] - PART 209—REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT

• Part 210 [§ 210.1 - § 210.3] - PART 210—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL

• Part 211 [§ 211.1 - § 211.208] - PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS

• Part 212 [§ 212.1 - § 212.110] - PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

• Part 213 - PART 213—XXX

• Part 216 [§ 216.23 - § 216.24] - PART 216—HUMAN DRUG COMPOUNDING

• Part 225 [§ 225.1 - § 225.202] - PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS

• Part 226 [§ 226.1 - § 226.115] - PART 226—CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES

• Part 230 - PART 230—XXX

• Part 250 [§ 250.11 - § 250.250] - PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS

• Part 251 [§ 251.1 - § 251.21] - PART 251—SECTION 804 IMPORTATION PROGRAM

• Part 290 [§ 290.1 - § 290.10] - PART 290—CONTROLLED DRUGS

• Part 299 [§ 299.3 - § 299.5] - PART 299—DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES